|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- June 18, 2008
CopyrightCOPYRIGHT 2008 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BrainStorm Cell Therapeutics Inc., of Petach Tikvah, Israel, said it was awarded $870,000 from Israel's Chief Scientist Office to fund the continuing development of treatments for amyotrophic lateral sclerosis and Parkinson's disease. The grant requires that the firm provide a 3 percent royalty to the Israeli government's Ministry of Trade and Industry program, which offers incentives to high-tech and biotech companies to enhance their research and development. The company previously was awarded a $340,000 grant by the CSO in 2007.
Cel-Sci Corp., of Vienna, Va., said preclinical results showed that its newly discovered peptide for rheumatoid arthritis, CEL-2000, ...